Payami H - Search Results

1

Cognitive and motor function in long-duration PARKIN-associated Parkinson disease.

Alcalay RN, Caccappolo E, Mejia-Santana H, Tang MX, Rosado L, Orbe Reilly M, Ruiz D, Louis ED, Comella CL, Nance MA, Bressman SB, Scott WK, Tanner CM, Mickel SF, Waters CH, Fahn S, Cote LJ, Frucht SJ, Ford B, Rezak M, Novak KE, Friedman JH, Pfeiffer RF, Marsh L, Hiner B, Payami H, Molho E, Factor SA, Nutt JG, Serrano C, Arroyo M, Ottman R, Pauciulo MW, Nichols WC, Clark LN, Marder KS. Alcalay RN, et al. Among authors: payami h. JAMA Neurol. 2014 Jan;71(1):62-7. doi: 10.1001/jamaneurol.2013.4498. JAMA Neurol. 2014. PMID: 24190026 Free PMC article.

2

HLA-A2, or a closely linked gene, confers susceptibility to early-onset sporadic Alzheimer's disease in men.

Payami H, Kaye J, Becker W, Norman D, Wetzsteon P. Payami H, et al. Neurology. 1991 Oct;41(10):1544-8. doi: 10.1212/wnl.41.10.1544. Neurology. 1991. PMID: 1922793

3

Increased risk of Parkinson's disease in parents and siblings of patients.

Payami H, Larsen K, Bernard S, Nutt J. Payami H, et al. Ann Neurol. 1994 Oct;36(4):659-61. doi: 10.1002/ana.410360417. Ann Neurol. 1994. PMID: 7605419

4

No evidence for association of familial Parkinson's disease with CAG repeat expansion.

Carĕro-Valenzuela R, Lindblad K, Payami H, Johnson W, Schalling M, Stenroos ES, Shattuc S, Nutt J, Brice A, Litt M. Carĕro-Valenzuela R, et al. Among authors: payami h. Neurology. 1995 Sep;45(9):1760-3. doi: 10.1212/wnl.45.9.1760. Neurology. 1995. PMID: 7675242

5

Genetic anticipation in Parkinson's disease.

Payami H, Bernard S, Larsen K, Kaye J, Nutt J. Payami H, et al. Neurology. 1995 Jan;45(1):135-8. doi: 10.1212/wnl.45.1.135. Neurology. 1995. PMID: 7824103 Clinical Trial.

6

Increased risk of familial late-onset Alzheimer's disease in women.

Payami H, Montee K, Grimslid H, Shattuc S, Kaye J. Payami H, et al. Neurology. 1996 Jan;46(1):126-9. doi: 10.1212/wnl.46.1.126. Neurology. 1996. PMID: 8559360

7

Evidence for association of HLA-A2 allele with onset age of Alzheimer's disease.

Payami H, Schellenberg GD, Zareparsi S, Kaye J, Sexton GJ, Head MA, Matsuyama SS, Jarvik LF, Miller B, McManus DQ, Bird TD, Katzman R, Heston L, Norman D, Small GW. Payami H, et al. Neurology. 1997 Aug;49(2):512-8. doi: 10.1212/wnl.49.2.512. Neurology. 1997. PMID: 9270587

8

Modulation of the age at onset of Parkinson's disease by apolipoprotein E genotypes.

Zareparsi S, Kaye J, Camicioli R, Grimslid H, Oken B, Litt M, Nutt J, Bird T, Schellenberg G, Payami H. Zareparsi S, et al. Among authors: payami h. Ann Neurol. 1997 Oct;42(4):655-8. doi: 10.1002/ana.410420417. Ann Neurol. 1997. PMID: 9382478

9

Genetic epidemiology of Parkinson's disease.

Payami H, Zareparsi S. Payami H, et al. J Geriatr Psychiatry Neurol. 1998 Summer;11(2):98-106. doi: 10.1177/089198879801100207. J Geriatr Psychiatry Neurol. 1998. PMID: 9877530 Review.

10

Exclusion of dominant mutations within the FTDP-17 locus on chromosome 17 for Parkinson's disease.

Zareparsi S, Wirdefeldt K, Burgess CE, Nutt J, Kramer P, Schalling M, Payami H. Zareparsi S, et al. Among authors: payami h. Neurosci Lett. 1999 Sep 10;272(2):140-2. doi: 10.1016/s0304-3940(99)00581-9. Neurosci Lett. 1999. PMID: 10507561

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

121 results

Search Page